Interview with William N. William Jr, MD, and Scott M. Lippman, MD, author of Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Oncology Author Interviews","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/jamaoncologyauthorinterviews\/Erlotinib_and_the_Risk_of_Oral_Cancer_JAMA_Oncology.mp3?dest-id=422099","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202106\/e089e1-0aee-220b-1ede23_800.jpg"},"title":"Erlotinib and the Risk of Oral Cancer","link":"javascript:;","id":"item-438026"}]
